Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PIQ-PHARMA CHEM is a Russian pharmaceutical company specializing in the development and industrial production of active pharmaceutical ingredients (APIs). As a key manufacturing arm of the PIQ-PHARMA group, the company operates a modern chemical synthesis facility located in Belgorod, which is designed in accordance with GMP standards. Its portfolio includes the synthesis of complex organic compounds used in neurology, cardiology, and metabolic treatments, most notably hopantenic acid and taurine. The company provides a full cycle of production from R&D to large-scale chemical manufacturing, supporting both internal group needs and external supply. PIQ-PHARMA CHEM plays a critical role in the Russian pharmaceutical supply chain by providing high-quality domestic raw materials for finished dosage forms. The facility is equipped for multi-stage organic synthesis and rigorous quality control to ensure compliance with international pharmacopoeia standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PIQ-PHARMA CHEM.